CD79A and colorectal carcinoma: Another study also found that anti-Fn-IgA and -IgG in the serum of patients with CRC were higher than those in patients with benign colorectal disease and healthy individuals (P < 0.001) (12), suggesting that blood microbiota markers also have a potential ability to detect CRC.